GENE ONLINE|News &
Opinion
Blog

2019-12-30| Technology

‘CRISPR Babies’ Researchers Given Prison Sentence by Chinese Court

by Rajaneesh K. Gopinath
Share To

By Rajaneesh K. Gopinath, Ph.D.

In November 2018, Chinese biophysicist He Jiankui shocked the world by announcing his creation of the “CRISPR babies” at an International Summit causing much furor across the globe. The researchers claimed that the intention of the study was to immunize the twin baby sisters Lulu and Nana against HIV by modifying the CCR5 gene in the embryo. However, a recent examination of the unpublished manuscripts by the MIT Technology Review involving four experts have found that the claims made by He and his team are not supported by data.

According to a report from Xinhua news agency, on December 30th, the Shenzhen Nanshan District People’s Court in South China has punished He and his coworkers Zhang Renli and Qin Jinzhou. The defendants were found to be guilty of jointly carrying out human embryo gene editing and reproductive medical activities for reproductive purposes. The court has found that the trio conspired since 2016 and has deliberately violated scientific regulations and crossed ethical boundaries.

While He Jiankui is sentenced to a three-year prison sentence including a fine of 3 million Chinese yuan (US$430,000), the others are given lesser sentences. Zhang Renli was sentenced to two years with a 1 million yuan fine and Qin Jinzhou received an 18-month sentence with a 500,000 yuan fine. All defendants pleaded guilty to the offense.

 

References
  1. https://mp.weixin.qq.com/s/5utIos-cXONVUh7Qn0Za9w
  2. https://www.technologyreview.com/s/614764/chinas-crispr-babies-read-exclusive-excerpts-he-jiankui-paper/

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Gilead Touts Long-Term Efficacy And Safety Data For HIV Drug
2022-10-26
Merck’s Phase 2 HIV Treatment Study Resumes with Phase 3 Program Announcement
2022-09-20
A Cure for HIV Could Be Here Sooner Than You Think – Future of Health
2022-09-16
LATEST
Targeting Metabolism for Noninvasive Multi-Cancer Early Detection Tests
2022-12-08
Moderna’s Personalized Cancer Therapy: The New Transformative Approach to Oncology
2022-12-08
SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France
2022-12-08
Relmada Blames ‘Implausible Placebo Results’ on Depression Drug’s Failure Again
2022-12-07
Using Sound Waves to Sort Blood-Based Nanoparticles
2022-12-07
Summit Bets $5 Billion On Akeso’s Bispecific Antibody
2022-12-07
Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH's Blood
2022-12-07
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
2023-01-09
JPM Annual Healthcare Meeting 2023
San Francisco, USA
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!